What Does a Positive TCA Drug Screen Mean?

A positive TCA drug screen means the test detected a substance in your urine that reacted with an antibody designed to recognize tricyclic antidepressants, a class of older medications used for depression, nerve pain, and migraine prevention. What it does not tell you is whether you actually have a tricyclic antidepressant in your system. These screens are notorious for flagging other medications that share a similar chemical shape, making false positives one of the most common and consequential problems in emergency toxicology.

How the Screening Test Works

Most hospitals and clinics use immunoassay-based urine tests to screen for tricyclic antidepressants. The test works by exposing your urine sample to antibodies that are designed to bind to the three-ringed molecular structure shared by drugs like amitriptyline, nortriptyline, imipramine, and doxepin. If enough binding occurs, the test reads positive.

The critical limitation is that this test is qualitative, not quantitative. It tells the clinician “yes, something TCA-like is present” or “no, nothing TCA-like was detected.” It cannot tell how much is there. A study comparing two widely used point-of-care urine immunoassays against quantitative blood analysis found that for virtually all positive urine TCA results, it was not possible to determine whether the positive corresponded to a dose that was below the therapeutic range, within it, above it, or frankly toxic.¹ This means a positive screen alone never answers the question a doctor actually needs answered in an emergency: is this person poisoned?

Even among true tricyclic antidepressants, the tests are uneven. That same study found that neither of the two immunoassays it tested could reliably detect clomipramine, even at blood concentrations above the therapeutic range.¹ So the screen can miss an actual TCA while simultaneously flagging a medication that isn’t one.

Why False Positives Are So Common

The antibodies in TCA immunoassays react to molecular shape, not molecular identity. Any compound that has a three-ringed (tricyclic) core structure, or that gets broken down into metabolites with a similar shape, can trigger a positive result. This is called cross-reactivity, and it is not a rare glitch. It is a well-documented feature of how these tests are built. The list of medications known to cause false-positive TCA results includes common prescriptions and even over-the-counter drugs that tens of millions of people take regularly.

The practical consequence is that if you show up at an emergency department after a seizure, a fainting spell, or an intentional ingestion, and the TCA screen comes back positive, the clinical team has to figure out whether you are genuinely dealing with a tricyclic antidepressant exposure or whether the test is reacting to something unrelated. Getting this distinction wrong can send treatment in the wrong direction.

Medications That Commonly Cause False Positives

Several broad drug classes are known offenders. Understanding which ones matter can help you advocate for yourself or a family member if a positive result does not match the person’s actual medication list.

Antihistamines

Diphenhydramine, the active ingredient in Benadryl, is one of the most frequently reported causes of a false-positive TCA screen. Tricyclic antidepressants and first-generation antihistamines share structural similarities and overlapping pharmacological effects, including anticholinergic activity and serotonin reuptake inhibition.² The cross-reactivity becomes relevant when diphenhydramine concentrations in urine climb above a certain threshold. One case report found that the TCA screen was negative at a urine diphenhydramine concentration of 100 micrograms per milliliter but turned positive at 500, suggesting that a kit-specific threshold exists between those levels.³ In overdose situations, diphenhydramine can easily reach those concentrations. The false positive can also persist in the urine for days after the initial exposure, which complicates repeat testing.

Other antihistamines that have been associated with false-positive TCA screens include cyproheptadine and trimeprazine.²

Antipsychotics

Quetiapine (sold under the brand name Seroquel) is a well-known cause of false-positive TCA screens, both at therapeutic doses and in overdose. A case study found that quetiapine triggered a positive result on two different TCA immunoassay platforms, with one assay turning positive at urine quetiapine levels as low as 10 micrograms per milliliter.⁴ This is clinically tricky because quetiapine overdose can look similar to TCA overdose on presentation, with sedation and changes in heart rhythm. A clinician relying on the screen alone might assume the patient took a tricyclic when in fact quetiapine is the culprit, and the two require somewhat different management.⁵

Older antipsychotics (phenothiazines) such as chlorpromazine and thioridazine are also documented cross-reactants.²

Cyclobenzaprine

Cyclobenzaprine is a widely prescribed muscle relaxant, and its molecular structure is almost identical to that of a tricyclic antidepressant. It routinely causes false-positive TCA screens.⁶ The rate at which it triggers a positive depends on which brand of immunoassay a lab uses; one comparison found that false positives from cyclobenzaprine were more common with one commercially available assay (the Biosite platform) than another (the Syva platform).¹ If you take cyclobenzaprine for back pain and end up in an emergency room, your TCA screen will very likely come back positive. Mentioning the medication proactively saves everyone time.

Carbamazepine

Carbamazepine is an anticonvulsant used for epilepsy and certain pain conditions. It has been identified as a false-positive trigger since the early days of TCA immunoassays.⁶ In at least one pediatric case, a child with carbamazepine toxicity was initially misidentified as having a TCA overdose based on the positive screen. The correct diagnosis only emerged after further workup. This is a clear example of how a false positive can delay appropriate care rather than just being an administrative nuisance.

What Happens After a Positive Screen

When a TCA screen comes back positive and the result is unexpected or the clinical picture does not quite fit, the next step is confirmatory testing. This typically means sending a blood or urine sample for analysis by a more precise method such as gas chromatography-mass spectrometry (GC-MS) or high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS).⁷ These methods identify the exact drug present and measure its concentration. An HPLC-MS/MS assay developed for pain management compliance testing was able to distinguish between 11 individual tricyclic antidepressants and their metabolites, as well as structurally similar compounds like cyclobenzaprine, with a lower limit of quantitation of 25 nanograms per milliliter for each one.⁸

The downside is turnaround time. Immunoassay results are available in minutes. Confirmatory chromatographic testing can take hours to days depending on the laboratory. In an emergency, the clinical team usually cannot wait for confirmation and must treat based on the combination of the screen result, the patient’s symptoms, and any available history about what the person might have taken.

How Clinicians Actually Assess TCA Toxicity

Because the urine screen cannot distinguish between a therapeutic dose and a life-threatening one, emergency physicians rely heavily on other clinical indicators. The most important single test is an electrocardiogram. Tricyclic antidepressant toxicity affects the heart’s electrical conduction system in a characteristic way, widening the QRS complex on the ECG tracing. A QRS interval at or above 100 milliseconds has been strongly correlated with the development of seizures and dangerous heart rhythms in TCA overdose.⁹ In a study of patients with severe TCA poisoning, the average peak QRS interval was 145 milliseconds, and roughly half developed seizures while about a quarter developed cardiac arrhythmias.⁹

Other signs of TCA toxicity include altered mental status, dilated pupils, dry mouth, urinary retention, rapid heart rate, and low blood pressure. When these symptoms cluster together with a widened QRS, the diagnosis is fairly clear regardless of the urine screen. Conversely, a positive urine screen in someone who is alert, has a normal ECG, and is on a known cross-reactive medication carries very different clinical significance. In that case, the positive result is almost certainly a false alarm.

Factors That Influence Detection

Even when the screen is genuinely detecting a tricyclic antidepressant, several factors determine whether your urine concentration crosses the threshold to trigger a positive result. Body mass, how dilute or concentrated your urine is, urine pH, and how well your liver and kidneys are functioning all affect the detection window. A person who is well-hydrated and producing large volumes of dilute urine may fall below the assay’s cutoff concentration even while still having the drug in their system. Conversely, someone who is dehydrated may produce concentrated urine that pushes a borderline level over the detection threshold. These variables mean the same dose of the same medication can produce a positive result in one person and a negative result in another.

Age and metabolism also play a role. Tricyclic antidepressants are extensively processed by the liver, and the metabolites themselves are often what the immunoassay detects. People who metabolize drugs more slowly, whether because of genetics, age, or liver disease, will carry both the parent drug and its metabolites in their system longer, widening the detection window.

Herbal Supplements and Over-the-Counter Products

If you take herbal supplements and are worried they might trip a TCA screen, the evidence is broadly reassuring. A study testing a panel of common supplements, including ginkgo biloba, saw palmetto, St. John’s wort, ginseng, garlic, green tea, valerian, and cranberry, found that none of them caused false-positive reactions on urine drug screens.⁷ The main over-the-counter concern remains diphenhydramine, as discussed above. At normal doses, diphenhydramine is unlikely to reach the urine concentrations needed to cross-react. The risk increases substantially in overdose or in people taking large doses for sleep.

What to Do if You Get an Unexpected Positive

If you are told your drug screen came back positive for tricyclic antidepressants and you do not take one, the most useful immediate step is to provide a complete list of every medication and supplement you take, including anything over the counter. Cyclobenzaprine, quetiapine, diphenhydramine, carbamazepine, and certain older antipsychotics are the most common culprits, and identifying them can prevent unnecessary treatment or an incorrect diagnosis.

Ask whether confirmatory testing has been ordered. If the clinical situation allows time for it, chromatographic confirmation will either identify the exact substance responsible or verify a true TCA presence and quantify it. In an emergency where you cannot communicate, having an up-to-date medication list in your wallet, phone, or medical record becomes even more valuable. Emergency teams make rapid decisions based on available information, and knowing that the patient takes quetiapine instead of amitriptyline changes the treatment plan.

When the Screen Shows Up in Non-Emergency Settings

TCA screens are not just used in emergency departments. They also appear in workplace drug testing panels, pain management compliance monitoring, and psychiatric treatment settings. The stakes differ in each context. In pain management, a positive TCA result is sometimes expected because the physician prescribed a tricyclic for chronic pain. The test is used to confirm the patient is actually taking the prescribed medication rather than diverting it. In that setting, more specific assays capable of identifying and quantifying individual tricyclics and their metabolites are preferred over standard immunoassays, because the goal is to distinguish between, say, amitriptyline and nortriptyline rather than simply detect “something TCA-like.”⁸

In workplace testing, standard panels do not always include TCAs, since tricyclic antidepressants are legal prescription medications rather than controlled substances. However, expanded panels or panels used in safety-sensitive industries sometimes do. A false positive in this context could have employment consequences, which is why confirmatory testing rights exist in most regulated drug testing programs. If your employer’s medical review officer contacts you about a positive TCA result, disclose your prescriptions, and request confirmation testing if the result does not match your medication history.

Why These Tests Persist Despite Their Limitations

Given how many false positives they produce and how little they reveal about actual drug levels, you might wonder why hospitals still use TCA immunoassays at all. The answer is speed and availability. In an emergency, a rapid point-of-care test that returns a result in minutes can guide initial treatment decisions. A full chromatographic workup takes hours, sometimes longer, and requires specialized laboratory equipment that not every facility has around the clock. The immunoassay is not meant to be the final word. It is meant to be a quick signal that, combined with the ECG, physical exam, and patient history, helps the clinical team decide how aggressively to treat. Problems arise when the test result is interpreted in isolation, without the clinical context that gives it meaning.

Researchers have acknowledged that immunoassays for tricyclic antidepressants need improvement.¹⁰ More specific antibodies or alternative rapid-testing platforms could reduce the false-positive rate, but developing, validating, and deploying new assays across thousands of hospitals takes time and money. For now, clinicians are trained to treat the patient rather than the screen. The best outcome happens when the person’s medication history, symptoms, and test results all point in the same direction. When they do not, the screen is the weakest link in that chain, and experienced clinicians know to question it.